Toll-like receptor 2 orchestrates a tumor suppressor response in non-small cell lung cancer
Author(s) -
Fraser R. Millar,
Adam Pennycuick,
Morwenna Muir,
Andrea Quintanilla,
Priya Hari,
Elisabeth Freyer,
Philippe Gautier,
Alison Meynert,
Graeme R. Grimes,
Carla Salomo Coll,
Sofía Zdral,
Stella Victorelli,
Vitor H. Teixeira,
John Connelly,
João F. Passos,
María A. Ros,
William Wallace,
Margaret C. Frame,
Andrew H. Sims,
Luke Boulter,
Sam M. Janes,
Simon Wilkinson,
Juan Carlos Acosta
Publication year - 2022
Publication title -
cell reports
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2022.111596
Subject(s) - tlr2 , carcinogenesis , cancer research , biology , lung cancer , cancer , tumor progression , proinflammatory cytokine , toll like receptor , immunology , senescence , tumor suppressor gene , cell cycle , oncogene , immune system , innate immune system , medicine , inflammation , microbiology and biotechnology , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom